153 related articles for article (PubMed ID: 25957418)
1. Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients.
Bagdonaite I; Wandall HH; Litvinov IV; Nastasi C; Becker JC; Dabelsteen S; Geisler C; Bonefeld CM; Zhang Q; Wasik MA; Zhou Y; Sasseville D; Ødum N; Woetmann A
Oncotarget; 2015 Jun; 6(16):14374-84. PubMed ID: 25957418
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous T cell lymphoma expresses immunosuppressive CD80 (B7-1) cell surface protein in a STAT5-dependent manner.
Zhang Q; Wang HY; Wei F; Liu X; Paterson JC; Roy D; Mihova D; Woetmann A; Ptasznik A; Odum N; Schuster SJ; Marafioti T; Riley JL; Wasik MA
J Immunol; 2014 Mar; 192(6):2913-9. PubMed ID: 24523507
[TBL] [Abstract][Full Text] [Related]
3. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
[TBL] [Abstract][Full Text] [Related]
4. Functional evaluation of activation-dependent alterations in the sialoglycan composition of T cells.
Naito-Matsui Y; Takada S; Kano Y; Iyoda T; Sugai M; Shimizu A; Inaba K; Nitschke L; Tsubata T; Oka S; Kozutsumi Y; Takematsu H
J Biol Chem; 2014 Jan; 289(3):1564-79. PubMed ID: 24297165
[TBL] [Abstract][Full Text] [Related]
5. A reevaluation of CD22 expression in human lung cancer.
Pop LM; Barman S; Shao C; Poe JC; Venturi GM; Shelton JM; Pop IV; Gerber DE; Girard L; Liu XY; Behrens C; Rodriguez-Canales J; Liu H; Wistuba II; Richardson JA; Minna JD; Tedder TF; Vitetta ES
Cancer Res; 2014 Jan; 74(1):263-71. PubMed ID: 24395821
[TBL] [Abstract][Full Text] [Related]
6. STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
Lindahl LM; Fredholm S; Joseph C; Nielsen BS; Jønson L; Willerslev-Olsen A; Gluud M; Blümel E; Petersen DL; Sibbesen N; Hu T; Nastasi C; Krejsgaard T; Jæhger D; Persson JL; Mongan N; Wasik MA; Litvinov IV; Sasseville D; Koralov SB; Bonefeld CM; Geisler C; Woetmann A; Ralfkiaer E; Iversen L; Odum N
Oncotarget; 2016 Jul; 7(29):45730-45744. PubMed ID: 27329723
[TBL] [Abstract][Full Text] [Related]
7. BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma.
Esmailzadeh S; Huang Y; Su MW; Zhou Y; Jiang X
Leukemia; 2015 Jun; 29(6):1402-13. PubMed ID: 25578476
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells.
Marzec M; Halasa K; Kasprzycka M; Wysocka M; Liu X; Tobias JW; Baldwin D; Zhang Q; Odum N; Rook AH; Wasik MA
Cancer Res; 2008 Feb; 68(4):1083-91. PubMed ID: 18281483
[TBL] [Abstract][Full Text] [Related]
10. CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo.
Haas KM; Sen S; Sanford IG; Miller AS; Poe JC; Tedder TF
J Immunol; 2006 Sep; 177(5):3063-73. PubMed ID: 16920943
[TBL] [Abstract][Full Text] [Related]
11. Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
Krejsgaard T; Vetter-Kauczok CS; Woetmann A; Kneitz H; Eriksen KW; Lovato P; Zhang Q; Wasik MA; Geisler C; Ralfkiaer E; Becker JC; Ødum N
Blood; 2009 Jun; 113(23):5896-904. PubMed ID: 19351960
[TBL] [Abstract][Full Text] [Related]
12. A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma.
van Doorn R; Dijkman R; Vermeer MH; Starink TM; Willemze R; Tensen CP
Cancer Res; 2002 Oct; 62(19):5389-92. PubMed ID: 12359741
[TBL] [Abstract][Full Text] [Related]
13. CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions.
Nakashima H; Hamaguchi Y; Watanabe R; Ishiura N; Kuwano Y; Okochi H; Takahashi Y; Tamaki K; Sato S; Tedder TF; Fujimoto M
J Immunol; 2010 May; 184(9):4637-45. PubMed ID: 20335532
[TBL] [Abstract][Full Text] [Related]
14. Possible therapeutic applicability of galectin-9 in cutaneous T-cell lymphoma.
Nakajima R; Miyagaki T; Kamijo H; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S
J Dermatol Sci; 2019 Dec; 96(3):134-142. PubMed ID: 31787505
[TBL] [Abstract][Full Text] [Related]
15. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
Nitschke L
Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
[TBL] [Abstract][Full Text] [Related]
16. CD22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapy.
Tuscano JM; Kato J; Pearson D; Xiong C; Newell L; Ma Y; Gandara DR; O'Donnell RT
Cancer Res; 2012 Nov; 72(21):5556-65. PubMed ID: 22986740
[TBL] [Abstract][Full Text] [Related]
17. Malignant T cells in cutaneous T-cell lymphoma lesions contain decreased levels of the antiapoptotic protein Ku70.
Ferenczi K; Ohtola J; Aubert P; Kessler M; Sugiyama H; Somani AK; Gilliam AC; Chen JZ; Yeh I; Matsuyama S; McCormick TS; Cooper KD
Br J Dermatol; 2010 Sep; 163(3):564-71. PubMed ID: 20408834
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Wu K; Lund M; Bang K; Thestrup-Pedersen K
Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
20. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
